TheraRadar
Data updated: Jun 28, 2026

HALCINONIDE · CHARTWELL RX

Generic · see HALOG-E Corticosteroid Hormone Receptor Agonists
Dermatology Approved 1974-11-27

Halcinonide cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Source: FDA Label
3
Indications
--
Phase 3 Trials
51
Years on Market

Details

Status
Prescription
First Approved
1974-11-27
Routes
TOPICAL
Dosage Forms
CREAM, SOLUTION

Companies

Active Ingredient: HALCINONIDE

HALCINONIDE Approval History

2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2019 to 2024
May 2024 ORIGINAL
Update
Sep 2021 ORIGINAL
Update
Aug 2019 ORIGINAL
Update

What HALCINONIDE Treats

1 indications

HALCINONIDE is approved for 1 conditions since its original approval in 2019. These indications span multiple therapeutic areas including oncology, immunology, and more.

Source: FDA Label

HALCINONIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to HALCINONIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ALA-SCALP
HYDROCORTISONE
1 shared
LEGACY PHARMA
Shared indications:
ALCLOMETASONE DIPROPIONATE
ALCLOMETASONE DIPROPIONATE
1 shared
GLENMARK PHARMS LTD
Shared indications:
AMCINONIDE
AMCINONIDE
1 shared
GENUS
Shared indications:
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HALCINONIDE FDA Label Details

Indications & Usage

Halcinonide cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Looking for the branded version?

HALOG-E

Full clinical data, patents, trials, and competitive landscape for halcinonide.

See HALOG-E

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.